Extravirgin olive oil up-regulates CB1 tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms

• Published in: The Journal of nutritional biochemistry 2015-03, Vol.26 (3), p.250-258
• Main Authors: Di Francesco, Andrea, Falconi, Anastasia, Di Germanio, Clara, Micioni Di Bonaventura, Maria Vittoria, Costa, Antonio, Caramuta, Stefano, Del Carlo, Michele, Compagnone, Dario, Dainese, Enrico, Cifani, Carlo, Maccarrone, Mauro, D’Addario, Claudio
• Format: Article
• Language: English
• Subjects: Animals; Bioactive lipids; Caco-2 Cells; Cell Line; Cell Proliferation; Colon; Colon - cytology; Colon - metabolism; Colon - pathology; Colonic Neoplasms - metabolism; Colonic Neoplasms - pathology; Colonic Neoplasms - prevention & control; Dietary Fats, Unsaturated - metabolism; Dietary Fats, Unsaturated - standards; Dietary Fats, Unsaturated - therapeutic use; DNA Methylation; Endocannabinoid system; Epigenesis, Genetic; Epigenetics; Female; Fruit - chemistry; Humans; Hydroxytyrosol; Intestinal Mucosa - cytology; Intestinal Mucosa - metabolism; Intestinal Mucosa - pathology; Neoplasm Proteins - agonists; Neoplasm Proteins - genetics; Neoplasm Proteins - metabolism; Olea - chemistry; Olive Oil; Phenolic compounds; Phenylethyl Alcohol - analogs & derivatives; Phenylethyl Alcohol - metabolism; Plant Extracts - metabolism; Plant Oils - chemistry; Plant Oils - metabolism; Plant Oils - standards; Promoter Regions, Genetic; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1 - agonists; Receptor, Cannabinoid, CB1 - chemistry; Receptor, Cannabinoid, CB1 - genetics; Receptor, Cannabinoid, CB1 - metabolism; Up-Regulation
• ISSN: 0955-2863; 1873-4847
• DOI: 10.1016/j.jnutbio.2014.10.013

Extravirgin olive oil (EVOO) represents the typical lipid source of the Mediterranean diet, an eating habit pattern that has been associated with a significant reduction of cancer risk. Diet is the more studied environmental factor in epigenetics, and many evidences suggest dysregulation of epigenetic pathways in cancer. The aim of our study was to investigate the effects of EVOO and its phenolic compounds on endocannabinoid system (ECS) gene expression via epigenetic regulation in both human colon cancer cells (Caco-2) and rats exposed to short- and long-term dietary EVOO. We observed a selective and transient up-regulation of CNR1 gene — encoding for type 1 cannabinoid receptor (CB1) — that was evoked by exposure of Caco-2 cells to EVOO (100 ppm), its phenolic extracts (OPE, 50 μM) or authentic hydroxytyrosol (HT, 50 μM) for 24 h. None of the other major elements of the ECS (i.e., CB2; GPR55 and TRPV1 receptors; and NAPE-PLD, DAGL, FAAH and MAGL enzymes) was affected at any time point. The stimulatory effect of OPE and HT on CB1 expression was inversely correlated to DNA methylation at CNR1 promoter and was associated with reduced proliferation of Caco-2 cells. Interestingly, CNR1 gene was less expressed in Caco-2 cells when compared to normal colon mucosa cells, and again this effect was associated with higher level of DNA methylation at CNR1. Moreover, in agreement with the in vitro studies, we also observed a remarkable (~4-fold) and selective increase in CB1 expression in the colon of rats receiving dietary EVOO supplementation for 10 days. Consistently, CpG methylation of rat Cnr1 promoter, miR23a and miR-301a, previously shown to be involved in the pathogenesis of colorectal cancer and predicted to target CB1 mRNA, was reduced after EVOO administration down to ~50% of controls. Taken together, our findings demonstrating CB1 gene expression modulation by EVOO or its phenolic compounds via epigenetic mechanism, both in vitro and in vivo, may provide a new therapeutic avenue for treatment and/or prevention of colon cancer.